Provided by Tiger Trade Technology Pte. Ltd.

UBS Group AG

47.04
-0.3800-0.80%
Volume:1.61M
Turnover:75.51M
Market Cap:144.04B
PE:16.35
High:47.12
Open:46.98
Low:46.55
Close:47.42
52wk High:55.99
52wk Low:36.30
Shares:3.06B
Float Shares:3.05B
Volume Ratio:0.92
T/O Rate:0.05%
Dividend:1.10
Dividend Rate:2.34%
EPS(TTM):2.88
EPS(LYR):2.36
ROE:10.67%
ROA:0.57%
PB:1.62
PE(LYR):19.93

Loading ...

UBS Fund Halts Fund Distribution Operations

Deep News
·
Sep 07

UBS Sticks to Its Buy Rating for Southern Cross Gold Consolidated Ltd. Chees Depository Interest Repr 1 shs (SX2)

TIPRANKS
·
Sep 07

Gentrack Group Says UBS Group Becomes Substantial Holder

MT Newswires Live
·
Sep 07

UBS emerges as substantial shareholder in Gentrack Group

TIPRANKS
·
Sep 07

UBS Group AG Ceases to Be Substantial Shareholder in Cochlear Limited

TIPRANKS
·
Sep 04

Zurich Closing Stock Prices

Dow Jones
·
Sep 04

Liberty LiLAC Rated Hold as Improving Cash Generation Offsets High Leverage and Valuation Premium

TIPRANKS
·
Sep 03

Market Chatter: UBS Faces Fresh Questions from US Senate Over Credit Suisse Nazi-Linked Accounts

MT Newswires Live
·
Sep 03

UBS Group AG exits substantial holder position in Cygnus Metals

TIPRANKS
·
Sep 03

UBS Group AG exits substantial shareholder position in Sonic Healthcare

TIPRANKS
·
Sep 03

UBS Group Ceases to Be Substantial Shareholder in EQT Holdings

TIPRANKS
·
Sep 03

Zurich Closing Stock Prices

Dow Jones
·
Sep 03

Holiday Inn Owner IHG Trades at Discount to Some Peers

Dow Jones
·
Sep 02

Major US Banks, Other Financial Groups Eye Establishing Stablecoin Enterprise in H2

MT Newswires Live
·
Sep 02

UBS Launches Tender Offers for Up to $6 Billion in Notes

MT Newswires Live
·
Sep 02

Morgan Stanley Remains a Sell on UBS Group AG (UBS)

TIPRANKS
·
Sep 02

UBS Remains a Buy on NexGen Energy Ltd. Shs Chess Depository Interests repr 1 shs (NXG)

TIPRANKS
·
Sep 02

UBS Snags $1.4 Billion Bernstein Private Wealth Management Team in L.A.

Dow Jones
·
Sep 02

UBS Gets a Win in Swiss Capital Battle

Dow Jones
·
Sep 01

Novartis's Multiple Sclerosis Trial Results Match Best Hopes

Dow Jones
·
Sep 01